Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Revue Medicale Suisse|June 9, 2005
[Role of intracellular signalling pathways in the development of type 1 diabetes]Christophe BonnyAdvances in Experimental Medicine and Biology|November 9, 2006
Blocking stress signaling pathways with cell permeable peptidesChristophe BonnyPlos One|May 8, 2012
JNK3 maintains expression of the insulin receptor substrate 2 (IRS2) in insulin-secreting cells: functional consequences for insulin signalingSaida Abdelli, Christophe BonnyTrends in Molecular Medicine|May 4, 2004
Use of cell-permeable peptides to prevent neuronal degenerationTiziana Borsello, Christophe BonnyReviews in the Neurosciences|April 7, 2005
Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseasesChristophe Bonny, Tiziana Borsello, Azel ZineBrain, Behavior, and Immunity|November 12, 2009
JNK inhibition and inflammation after cerebral ischemiaCorinne Benakis, Christophe Bonny, Lorenz HirtCerebrovascular Diseases (Basel, Switzerland)|April 9, 2010
c-Jun N-terminal kinase pathway inhibition in intracerebral hemorrhageDelphine Michel-Monigadon, Christophe Bonny, Lorenz HirtCerebrovascular Diseases (Basel, Switzerland)|August 30, 2008
The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activatorKarine Wiegler, Christophe Bonny, Didier Coquoz, et al.The European Journal of Neuroscience|March 30, 2010
c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticusGiada Spigolon, Carlo Veronesi, Christophe Bonny, et al.NAR Genomics and Bioinformatics|May 31, 2021
GeneMark-HM: improving gene prediction in DNA sequences of human microbiomeAlexandre Lomsadze, Christophe Bonny, Francesco Strozzi, et al.Pageof 5